Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|June 9, 2018
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkersSéverine Guiu, Caroline Mollevi, Céline Charon-Barra, et al.
BMC Cancer|February 21, 2014
Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in FranceFlorence Menegaux, Antoinette Anger, Hasina Randrianasolo, et al.
Cancers|October 21, 2020
Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison StudyPierre-Jean Lamy, Paul van der Leest, Nicolas Lozano, et al.
Occupational and Environmental Medicine|June 21, 2018
Night work and prostate cancer risk: results from the EPICAP StudyMéyomo Gaelle Wendeu-Foyet, Virginie Bayon, Sylvie Cénée, et al.
Cancers|April 3, 2020
BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast CancerWilliam Jacot, Evelyne Lopez-Crapez, Caroline Mollevi, et al.
World Journal of Urology|January 2, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic reviewYanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié, et al.
Bulletin Du Cancer|October 9, 2024
[Precision medicine in oncology: A reality… without equity]Frédérique Pénault-Llorca, Clarisse Audigier-Valette, Pierre-Jean Lamy, et al.
Annales De Biologie Clinique|December 21, 2019
[Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives]Jérôme Alexandre Denis, Alexandre Perrier, Juliette Nectoux, et al.
Breast Cancer Research and Treatment|July 13, 2019
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapyWilliam Jacot, Florence Dalenc, Evelyne Lopez-Crapez, et al.
European Urology Oncology|June 1, 2024
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic ReviewMichael Baboudjian, Arthur Peyrottes, Charles Dariane, et al.
Pageof 9